I was bearish on General Electric (GE) prior to the knock-on effects of COVID-19. The pandemic has practically brought business activity to a standstill, hurting corporations like GE. The company hived off some of its most-attractive assets when the U.S. economy was demonstrating signs of growth. What happens with GE’s remaining industrial assets now that the economy is collapsing? Once the pandemic subsides, there is still no guarantee the economy will be able to sustain long-term growth.
GE had previously defined its core businesses as Power, Renewable Energy and Aviation. Now that Biopharma has been sold, it seems appropriate to analyze Healthcare ex-Biopharma as well. GE’s industrial businesses – Power, Renewable Energy, Aviation and Healthcare – reported Q2 revenue of $15.9 billion, down 25% Y/Y. Read more: